Concepedia

Maria Lopez-Bresnahan

ML

12

Publications

684

Citations

11

H-Index

1992

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Ono Pharmaceutical (United States)

Optum (United States)

Biogen (United States)

Maria Lopez-Bresnahan is an author at Harvard University specializing in medicine, social sciences, and neurology.

Top concepts

Publications per year

1992–2019

12

Publications

12

Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims

Benjamin Chastek, MerriKay Oleen-Burkey, Maria Lopez-Bresnahan · Journal of Medical Economics · 2010 · 100 citations · Full text

Exacerbation or Unmasking of Focal Neurologic Deficits by Sedatives

Gary Thal, Michele D. Szabo, Maria Lopez-Bresnahan et al. · Anesthesiology · 1996 · 81 citations · Full text

The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis

Scott B. Patten, Gordon Francis, Luanne M. Metz et al. · Multiple Sclerosis Journal · 2005 · 79 citations

Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a

Steven R. Schwid, Michael D. Decker, Maria Lopez-Bresnahan · Neurology · 2005 · 67 citations

, , +14

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

Robert T. Naismith, Jerry S. Wolinsky, Annette Wundes et al. · Multiple Sclerosis Journal · 2019 · 62 citations · Full text

Rows per page

1–5 of 12